Bio-Rad Laboratories BIO
NYSE BIO
$376.77 +12.51 (+3.43%)
At close: Aug 20, 2026 · 1:14 PM UTC

Bio-Rad Laboratories (BIO) Share-based Compensation (QoQ) (2009 - 2025)

Bio-Rad Laboratories (BIO) Share-based Compensation (QoQ) (2009 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 199.24 Bn 193.64 Bn 7.27 Bn
2 Stryker 128.63 Bn 125.15 Bn 4.50 Bn
3 Medtronic 119.19 Bn 109.97 Bn 6.41 Bn
4 Boston Scientific 73.51 Bn 72.97 Bn 3.85 Bn
5 Edwards Lifesciences 52.11 Bn 47.85 Bn 1.35 Bn
6 Dexcom 34.64 Bn 32.70 Bn 830.00 Mn
7 GE HealthCare Technologies 34.01 Bn 31.90 Bn 2.18 Bn
8 Koninklijke Philips 26.40 Bn 23.08 Bn 4.55 Bn
9 Steris 23.14 Bn 22.65 Bn 684.20 Mn
10 Bio-Rad Laboratories 10.08 Bn 8.46 Bn 345.80 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 101.63%
Dec 31, 2024 -372.44%
Dec 31, 2023 -167.43%
Dec 31, 2022 100.94%
Sep 30, 2022 -197.24%
Jun 30, 2022 0.74%
Mar 31, 2022 198.41%
Dec 31, 2021 -138.43%
Sep 30, 2021 418.89%
Jun 30, 2021 -195.67%
Mar 31, 2021 171.47%
Dec 31, 2020 -251.57%
Sep 30, 2020 22.73%
Jun 30, 2020 -9.28%
Mar 31, 2020 -64.73%
Dec 31, 2019 567.57%
Sep 30, 2019 191.07%
Jun 30, 2019 -153.22%
Mar 31, 2019 -55.12%
Dec 31, 2018 684.87%